MA51185A - Compositions comprenant des souches bactériennes - Google Patents
Compositions comprenant des souches bactériennesInfo
- Publication number
- MA51185A MA51185A MA051185A MA51185A MA51185A MA 51185 A MA51185 A MA 51185A MA 051185 A MA051185 A MA 051185A MA 51185 A MA51185 A MA 51185A MA 51185 A MA51185 A MA 51185A
- Authority
- MA
- Morocco
- Prior art keywords
- bacterial strains
- compositions containing
- containing bacterial
- compositions
- strains
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des compositions comprenant des souches bactériennes destinées à être utilisées en thérapie.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18179641 | 2018-06-25 | ||
| GBGB1814836.1A GB201814836D0 (en) | 2018-09-12 | 2018-09-12 | Compositions comprising bacterial strains |
| GBGB1905000.4A GB201905000D0 (en) | 2019-04-09 | 2019-04-09 | Compositions comprising bacterial strains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA51185A true MA51185A (fr) | 2020-10-21 |
| MA51185B1 MA51185B1 (fr) | 2021-07-29 |
Family
ID=67667788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51185A MA51185B1 (fr) | 2018-06-25 | 2019-06-25 | Compositions comprenant des souches bactériennes |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20210085728A1 (fr) |
| EP (2) | EP3723777B1 (fr) |
| JP (2) | JP6987259B2 (fr) |
| KR (1) | KR102383535B1 (fr) |
| CN (1) | CN112912090A (fr) |
| AU (2) | AU2019294284B2 (fr) |
| CA (1) | CA3103161C (fr) |
| CY (1) | CY1124623T1 (fr) |
| DK (1) | DK3723777T3 (fr) |
| ES (1) | ES2887903T3 (fr) |
| HR (1) | HRP20210772T1 (fr) |
| HU (1) | HUE054904T2 (fr) |
| IL (1) | IL279724B (fr) |
| LT (1) | LT3723777T (fr) |
| MA (1) | MA51185B1 (fr) |
| MD (1) | MD3723777T2 (fr) |
| PL (1) | PL3723777T3 (fr) |
| RS (1) | RS61972B1 (fr) |
| SG (1) | SG11202012221YA (fr) |
| SI (1) | SI3723777T1 (fr) |
| TW (1) | TW202019446A (fr) |
| WO (1) | WO2020002370A1 (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| KR20180083894A (ko) * | 2015-11-24 | 2018-07-23 | 세레스 테라퓨틱스, 인코포레이티드 | 설계된 박테리아 조성물 |
| AU2017234120A1 (en) * | 2016-03-14 | 2018-09-20 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
-
2019
- 2019-06-25 AU AU2019294284A patent/AU2019294284B2/en active Active
- 2019-06-25 RS RS20210731A patent/RS61972B1/sr unknown
- 2019-06-25 JP JP2020540266A patent/JP6987259B2/ja active Active
- 2019-06-25 MA MA51185A patent/MA51185B1/fr unknown
- 2019-06-25 LT LTEP19755806.7T patent/LT3723777T/lt unknown
- 2019-06-25 DK DK19755806.7T patent/DK3723777T3/da active
- 2019-06-25 WO PCT/EP2019/066905 patent/WO2020002370A1/fr active Search and Examination
- 2019-06-25 SI SI201930063T patent/SI3723777T1/sl unknown
- 2019-06-25 TW TW108122216A patent/TW202019446A/zh unknown
- 2019-06-25 EP EP19755806.7A patent/EP3723777B1/fr active Active
- 2019-06-25 SG SG11202012221YA patent/SG11202012221YA/en unknown
- 2019-06-25 HU HUE19755806A patent/HUE054904T2/hu unknown
- 2019-06-25 CA CA3103161A patent/CA3103161C/fr active Active
- 2019-06-25 MD MDE20201083T patent/MD3723777T2/ro unknown
- 2019-06-25 EP EP21165418.1A patent/EP3922256A1/fr active Pending
- 2019-06-25 PL PL19755806T patent/PL3723777T3/pl unknown
- 2019-06-25 CN CN201980051210.4A patent/CN112912090A/zh active Pending
- 2019-06-25 KR KR1020217002203A patent/KR102383535B1/ko active IP Right Grant
- 2019-06-25 ES ES19755806T patent/ES2887903T3/es active Active
-
2020
- 2020-10-02 US US17/062,239 patent/US20210085728A1/en not_active Abandoned
- 2020-12-23 IL IL279724A patent/IL279724B/en unknown
-
2021
- 2021-05-13 HR HRP20210772TT patent/HRP20210772T1/hr unknown
- 2021-06-14 CY CY20211100528T patent/CY1124623T1/el unknown
- 2021-06-25 AU AU2021204337A patent/AU2021204337A1/en active Pending
- 2021-11-30 JP JP2021194935A patent/JP2022033856A/ja active Pending
-
2022
- 2022-08-17 US US17/820,252 patent/US20230134714A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MA51185B1 (fr) | 2021-07-29 |
| JP6987259B2 (ja) | 2021-12-22 |
| IL279724A (en) | 2021-03-01 |
| JP2021522160A (ja) | 2021-08-30 |
| KR102383535B1 (ko) | 2022-04-08 |
| US20230134714A1 (en) | 2023-05-04 |
| CN112912090A (zh) | 2021-06-04 |
| CA3103161C (fr) | 2021-12-14 |
| LT3723777T (lt) | 2021-06-10 |
| EP3922256A1 (fr) | 2021-12-15 |
| SI3723777T1 (sl) | 2021-08-31 |
| WO2020002370A1 (fr) | 2020-01-02 |
| SG11202012221YA (en) | 2021-01-28 |
| HUE054904T2 (hu) | 2021-10-28 |
| IL279724B (en) | 2022-05-01 |
| AU2021204337A1 (en) | 2021-07-22 |
| AU2019294284B2 (en) | 2021-03-25 |
| TW202019446A (zh) | 2020-06-01 |
| EP3723777B1 (fr) | 2021-03-31 |
| US20210085728A1 (en) | 2021-03-25 |
| ES2887903T3 (es) | 2021-12-28 |
| MD3723777T2 (ro) | 2021-09-30 |
| DK3723777T3 (da) | 2021-05-25 |
| RS61972B1 (sr) | 2021-07-30 |
| CA3103161A1 (fr) | 2020-01-02 |
| CY1124623T1 (el) | 2022-07-22 |
| PL3723777T3 (pl) | 2021-10-04 |
| HRP20210772T1 (hr) | 2021-09-17 |
| AU2019294284A1 (en) | 2021-02-04 |
| JP2022033856A (ja) | 2022-03-02 |
| EP3723777A1 (fr) | 2020-10-21 |
| KR20210021085A (ko) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44322A (fr) | Compositions comprenant des souches bactériennes | |
| MA42471A (fr) | Compositions comprenant des souches bactériennes | |
| MA41013B1 (fr) | Compositions comprenant des souches bactériennes | |
| MA44890A (fr) | Compositions comprenant des souches bactériennes | |
| MA42351B1 (fr) | Compositions comprenant des souches bactériennes | |
| MA53937B1 (fr) | Compositions comprenant des souches bactériennes | |
| MA41060A (fr) | Compositions comprenant des souches bactériennes | |
| MA55434B1 (fr) | Compositions comprenant des souches bactériennes | |
| MA41010A (fr) | Compositions comprenant des souches bactériennes | |
| MA52128A (fr) | Compositions comprenant des souches bactériennes | |
| MA48939A (fr) | Compositions comprenant des souches bactériennes | |
| MA49373A (fr) | Compositions comprenant des souches bactériennes | |
| EP4293116A3 (fr) | Fibrinogène liquide stable | |
| MA53860A (fr) | Compositions comprenant des souches bactériennes | |
| MA53155A (fr) | Compositions comprenant des souches bactériennes | |
| MA53228A (fr) | Compositions comprenant des souches bactériennes | |
| MA51185A (fr) | Compositions comprenant des souches bactériennes | |
| MA52874A (fr) | Formulations/compositions comprenant de l'ibrutinib | |
| EA202190554A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| MA51709A (fr) | Compositions comprenant des souches bactériennes | |
| MA49322A (fr) | Compositions comprenant des souches bactériennes | |
| MA54074A (fr) | Compositions comprenant des souches bactériennes | |
| MA45200A (fr) | Compositions comprenant des souches bactériennes | |
| MA45476A (fr) | Compositions comprenant des souches bactériennes | |
| WO2020115095A3 (fr) | Procédés et compositions pour la prévention et/ou le traitement de l'ischémie et de la lésion d'ischémie-reperfusion |